Find information on thousands of medical conditions and prescription drugs.

Hearing impairment

A hearing impairment is a decrease in one's ability to hear (i.e. perceive auditory information). While some cases of hearing loss are reversible with medical treatment, many lead to a permanent disability (often called deafness). more...

Home
Diseases
A
B
C
D
E
F
G
H
Hairy cell leukemia
Hallermann Streiff syndrome
Hallux valgus
Hantavirosis
Hantavirus pulmonary...
HARD syndrome
Harlequin type ichthyosis
Harpaxophobia
Hartnup disease
Hashimoto's thyroiditis
Hearing impairment
Hearing loss
Heart block
Heavy metal poisoning
Heliophobia
HELLP syndrome
Helminthiasis
Hemangioendothelioma
Hemangioma
Hemangiopericytoma
Hemifacial microsomia
Hemiplegia
Hemoglobinopathy
Hemoglobinuria
Hemolytic-uremic syndrome
Hemophilia A
Hemophobia
Hemorrhagic fever
Hemothorax
Hepatic encephalopathy
Hepatitis
Hepatitis A
Hepatitis B
Hepatitis C
Hepatitis D
Hepatoblastoma
Hepatocellular carcinoma
Hepatorenal syndrome
Hereditary amyloidosis
Hereditary angioedema
Hereditary ataxia
Hereditary ceroid...
Hereditary coproporphyria
Hereditary elliptocytosis
Hereditary fructose...
Hereditary hemochromatosis
Hereditary hemorrhagic...
Hereditary...
Hereditary spastic...
Hereditary spherocytosis
Hermansky-Pudlak syndrome
Hermaphroditism
Herpangina
Herpes zoster
Herpes zoster oticus
Herpetophobia
Heterophobia
Hiccups
Hidradenitis suppurativa
HIDS
Hip dysplasia
Hirschsprung's disease
Histoplasmosis
Hodgkin lymphoma
Hodgkin's disease
Hodophobia
Holocarboxylase...
Holoprosencephaly
Homocystinuria
Horner's syndrome
Horseshoe kidney
Howell-Evans syndrome
Human parvovirus B19...
Hunter syndrome
Huntington's disease
Hurler syndrome
Hutchinson Gilford...
Hutchinson-Gilford syndrome
Hydatidiform mole
Hydatidosis
Hydranencephaly
Hydrocephalus
Hydronephrosis
Hydrophobia
Hydrops fetalis
Hymenolepiasis
Hyperaldosteronism
Hyperammonemia
Hyperandrogenism
Hyperbilirubinemia
Hypercalcemia
Hypercholesterolemia
Hyperchylomicronemia
Hypereosinophilic syndrome
Hyperhidrosis
Hyperimmunoglobinemia D...
Hyperkalemia
Hyperkalemic periodic...
Hyperlipoproteinemia
Hyperlipoproteinemia type I
Hyperlipoproteinemia type II
Hyperlipoproteinemia type...
Hyperlipoproteinemia type IV
Hyperlipoproteinemia type V
Hyperlysinemia
Hyperparathyroidism
Hyperprolactinemia
Hyperreflexia
Hypertension
Hypertensive retinopathy
Hyperthermia
Hyperthyroidism
Hypertrophic cardiomyopathy
Hypoaldosteronism
Hypocalcemia
Hypochondrogenesis
Hypochondroplasia
Hypoglycemia
Hypogonadism
Hypokalemia
Hypokalemic periodic...
Hypoparathyroidism
Hypophosphatasia
Hypopituitarism
Hypoplastic left heart...
Hypoprothrombinemia
Hypothalamic dysfunction
Hypothermia
Hypothyroidism
Hypoxia
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
Medicines

If the hearing loss occurs at a young age, it may interfere with the acquisition of spoken language and social development. Hearing aids and cochlear implants may alleviate some of the problems caused by hearing impairment, but are often insufficient. People who have hearing impairments, especially those who develop a hearing problem later in life, often require support and technical adaptations as part of the rehabilitation process.

Causes

There are four major causes of hearing loss: genetic, disease processes affecting the ear, medication and physical trauma.

Genetic

Hearing loss can be inherited. Both dominant and recessive genes exist which can cause mild to profound impairment. If a family has a dominant gene for deafness it will persist across generations because it will manifest itself in the offspring even if it is inherited from only one parent. If a family had genetic hearing impairment caused by a recessive gene it will not always be apparent as it will have to be passed onto offspring from both parents.

Dominant and recessive hearing impairment can be syndromic or nonsyndromic. Recent gene mapping has identified dozens of nonsyndromic dominant (DFNA#) and recessive (DFNB#) forms of deafness.

  • The most common type of congenital hearing impairment in developed countries is DFNB1, also known as Connexin 26 deafness or GJB2-related deafness.
  • The most common dominant syndromic forms of hearing impairment include Stickler syndrome and Waardenburg syndrome.
  • The most common recessive syndromic forms of hearing impairment are Pendred syndrome, Large vestibular aqueduct syndrome and Usher syndrome.

Disease or illness

  • Measles may result in auditory nerve damage
  • Meningitis may damage the auditory nerve or the cochlea
  • Autoimmune disease has only recently been recognised as a potential cause for cochlear damage. Although probably rare, it is possible for autoimmune processes to target the cochlea specifically, without symptoms affecting other organs. Wegener's granulomatosis is one of the autoimmune conditions that may precipiate hearing loss.
  • Presbyacusis is deafness due to loss of perception to high tones, mainly in the elderly. It is considered a degenerative process, and it is poorly understood why some elderly people develop presbyacusis while others do not.
  • Mumps (Epidemic parotitis) may result in profound sensorineural hearing loss (90 dB or more), unilateral (one ear) or bilateral (both ears).
  • Adenoids that do not disappear by adolescence may continue to grow and may obstruct the Eustachian tube, causing conductive hearing impairment and nasal infections that can spread to the middle ear.
  • AIDS and ARC patients frequently experience auditory system anomalies.
  • HIV (and subsequent opportunistic infections) may directly affect the cochlea and central auditory system.
  • Chlamydia may cause hearing loss in newborns to whom the disease has been passed at birth.
  • Fetal alcohol syndrome is reported to cause hearing loss in up to 64% of infants born to alcoholic mothers, from the ototoxic effect on the developing fetus plus malnutrition during pregnancy from the excess alcohol intake.
  • Premature birth results in sensorineural hearing loss approximately 5% of the time.
  • Syphilis is commonly transmitted from pregnant women to their fetuses, and about a third of the infected children will eventually become deaf.
  • Otosclerosis is a hardening of the stapes (or stirrup) in the middle ear and causes conductive hearing loss.

Read more at Wikipedia.org


[List your site here Free!]


Should we recommend universal neonatal hearing screening?
From Journal of Family Practice, 8/1/05 by Johnathan M. Compton

EVIDENCE-BASED ANSWER

Universal neonatal hearing screening leads to both earlier detection and earlier treatment of infants with hearing loss (strength of recommendation [SOR]: A, based on a systematic review). Available evidence suggests early identification and intervention may improve language outcomes (SOR: C, based on retrospective cohort studies).

CLINICAL COMMENTARY

Despite lack of evidence, early intervention could aid future language skills

Despite the lack of hard outcomes data to support neonatal hearing screening, it seems reasonable that early intervention will aid future language skills. Hopefully, future evidence will support the notion that early treatment leads to tangible school performance improvement. For most, however, the decision to universally screen neonates will be guided by state law rather than clinical evidence alone; 38 states currently have mandated screening programs with legislation pending in others.

* Evidence summary

In the United States, approximately 5000 infants with moderate-to-profound hearing loss are born annually. (1) Affected children graduate high school averaging 4th-grade academic performance skills. (2) Efforts to reduce the impact on these children have focused on early diagnosis and treatment.

A systematic review gathered studies comparing universal hearing screening with selective screening. (1) Most included studies used a 2-stage universal screening protocol. Infants who failed initial testing were retested within 12 weeks. Testing methods included otoacoustic emissions (OAE) and auditory brainstem response (ABR). Infants who failed the second test were referred for audiological evaluation. Using these data, a hypothetical model was created, which found that 1441 newborns would need to be screened to diagnose 1 additional case of moderate-to-profound permanent hearing loss before 10 months of age (at cost of 200 extra referrals for false-positives). Sensitivity and specificity of the hypothetical model's 2-stage screening was 85% and 97%, respectively. The estimated positive predictive value was 6.7%. (1,3)

Individually, OAE and ABR accurately diagnose neonatal hearing loss. One multicenter cohort of 2995 infants measured test performance of OAE and ABR against the gold standard (visual reinforcement audiometry performed at 8-12 months). (4) The authors used a receiver operating characteristics (ROC) curve to plot speech awareness thresholds for both tests. When middle-ear pathology and progressive hearing loss were excluded, the area under the ROC curves for ABR and OAE were 0.91 and 0.94, respectively, indication that both tests had excellent test accuracy (a perfect test would have an area under the curve of 1.0).

Strategies based on selective screening of high-risk infants fails to identify permanent hearing loss in many affected infants. In a cohort study of more than 10,000 infants, only 43% of infants with permanent hearing loss were identified with selective versus universal screening. Most affected infants would have been missed using risk-based criteria. (5)

Limited evidence suggests that early identification of infants with permanent hearing loss improves language skills. In a retrospective cohort study of 150 infants examining language outcomes, participants were grouped according to age at identification of hearing loss. (6) All participants received comprehensive in-home language intervention services plus amplification devices.

Of the 85 children with normal cognitive ability, the mean receptive and expressive language quotients at 13 to 36 months were higher in the early-identified group vs the late-identified group (receptive language quotients, 79.6 vs 64.6, P<.001; expressive language quotients, 78.3 vs 63.1, P<.001). Total language quotient was also higher in the early group (language quotients, 79 vs 64; P<.001).

The conclusions were limited by multiple factors: retrospective study design, cohort selection drawn from different hospitals during different time periods, unblinded participant selection, and unblended outcome assessments. Other published studies have inconclusive outcome data. The Cochrane Collaboration published a systematic review in which no studies were found that fulfilled the inclusion criteria to evaluate the effectiveness of universal hearing screening. (7)

Recommendations from others

The Joint Committee on Infant Hearing recommended universal neonatal hearing screening during hospital birth admission in their Year 2000 Position Statement. (8) For infants whose hearing is impaired on re-screening, the committee recommends audiology referral and medical evaluation to rule out associated conditions before age 3 months. They further recommend interventional services begin before age 6 months for infants with confirmed hearing loss.

The US Preventive Services Task Force does not recommend for or against universal hearing screening, citing insufficient outcomes data. (9)

REFERENCES

(1.) Thompson DC, McPhillips H, Davis RL, Lieu TL, Homer CJ, Helfand M. Universal newborn hearing screening, summary of evidence. JAMA 2001; 256:2000-2010.

(2.) Holt JA. Stanford Achievement Test--8th edition: reading comprehension subgroup results. Am Ann Deaf 1993; 138:172-175.

(3.) Controlled trial of universal neonatal screening for early identification of permanent childhood hearing impairment. Wessex Universal Neonatal Hearing Screening Trial Group. Lancet 1998; 352:1957-1964.

(4.) Norton SJ, Gorga MP, Widen S J, et al. Identification of neonatal hearing impairment: evaluation of transient evoked otoacoustic emission, distortion product otoacoustic emission, and auditory brainstem response test performance. Ear Hear 2000; 21:508-528.

(5.) Watkin PM, Baldwin M, McEnery G. Neonatal at risk screening and the identification of deafness. Arch Dis Child 1991; 66(10 Spec No):1130-1135.

(6.) Yoshinaga-Itano C, Sedey AL, Coulter DK, Mehl AL. Language of early- and later-identified children with hearing loss. Pediatrics 1998; 102:1161-1171.

(7.) Puig T, Municio A, Meda C. Universal neonatal hearing screening versus selective screening as part of the management of childhood deafness. Cochrane Database Syst Rev 2005 (2):CD003731.

(8.) Joint Committee on Infant Hearing, American Academy of Audiology, American Academy of Pediatrics, American Speech-Language-Hearing Association, Directors of Speech and Hearing Programs in State Health and Welfare Agencies. Year 2000 position statement: Principles and guidelines for early hearing detection and intervention programs. Pediatrics 2000; 106:798-817.

(9.) US Preventive Services Task Force. Newborn Hearing Screening: Recommendations and Rationale. October 2001. Agency for Healthcare Research and Quality, Rockville, Md. Available at: www.ahrq.gov/clinic/ 3rduspstf/newbornscreen/newhearrr.htm. Accessed on July 6, 2005.

FAST TRACK

Evidence suggests that early intervention may improve language skills for infants with hearing loss

Johnathan M. Compton, MD

Family Medicine Residency, Offutt Air Force Base/University of Nebraska, Omaha

Brian K. Crownover, MD, FAAFP

96th Medical Group, Family Medicine Residency, Eglin Air Force Base, Eglin, Fla

Joan Nashelsky, MLS

Family Physicians Inquiries Network, Iowa City

COPYRIGHT 2005 Dowden Health Media, Inc.
COPYRIGHT 2005 Gale Group

Return to Hearing impairment
Home Contact Resources Exchange Links ebay